Loading
Macrolide·Infectious Diseases - Macrolides
Atypical pneumonia (Legionella, Mycoplasma), Chlamydia, Pertussis, severe Campylobacter
Max Dose
500 mg/day
Half-life
68 h
QTc Risk
HIGH
CYP3A4
WEAK
Overview
Unique macrolide that rapidly leaves the blood and concentrates massively inside phagocytes and tissues. Delivers localized therapy for days after the last dose.
Maximum Dose
Max 500 mg/day (or 1g single STAT dose for STIs).
Clinical Focus
Known to prolong the QTc interval. However, it lacks the severe CYP3A4 drug interactions seen with Clarithromycin.
Bottom Line
Azithromycin is a convenient 3-5 day macrolide for atypical pneumonia, STIs, and penicillin-allergic patients, but prolongs QTc and has significant drug interactions via CYP3A4.
Brand Names
Zithromax
Oral Routes
Tablets (500 mg). Oral liquid.
Parenteral
Ampoule (500 mg) for IV use.
Prescribing & PBS
Unrestricted General Benefit (S4).
Primary
Atypical pneumonia (Legionella, Mycoplasma), Chlamydia, Pertussis, severe Campylobacter.
Off-Label
Prokinetic for severe gastroparesis (IV). Chronic inflammation reduction in COPD.
Clinical Place
First-line empirical addition to Ceftriaxone for severe CAP to cover 'atypicals'.